Tag: Pharmaceutical Whistleblower Blog

PHARMACEUTICAL WHISTLEBLOWER BLOG: Pharmaceutical Company Daiichi to Pay $39 Million to Settle Fraud Allegations Involving Improper Kickbacks

On January 9, 2015, the Department of Justice announced that Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, agreed to pay the federal government and state Medicaid programs $39 million to ...

Continue reading

PHARMACEUTICAL WHISTLEBLOWER BLOG: Whistleblower Lawsuit Against Novartis Survives Motion to Dismiss

Recently, a federal district judge in the Southern District of New York denied, in part, Novartis’ motion to dismiss a whistleblower lawsuit filed under the civil False Claims Act. The pharmaceutical whistleblower alleged that Novartis ...

Continue reading

PHARMACEUTICAL WHISTLEBLOWER BLOG: CVS Caremark to Pay $6 Million to Settle Whistleblower Lawsuit

Caremark, LLC, a pharmacy benefit management (PBM) company operated by CVS Caremark Corporation, recently agreed to pay the federal government $6 million to settle a whistleblower lawsuit brought under the federal False Claims Act. The ...

Continue reading

Menu Title